Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Increase in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 65 shares, an increase of 170.8% from the September 15th total of 24 shares. Based on an average daily volume of 1,647 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are short sold.

Innovator IBD Breakout Opportunities ETF Stock Performance

NYSEARCA:BOUT traded down $0.73 during trading hours on Wednesday, hitting $41.58. 647 shares of the company’s stock traded hands, compared to its average volume of 3,534. The firm has a market cap of $14.55 million, a P/E ratio of 28.69 and a beta of 1.04. Innovator IBD Breakout Opportunities ETF has a twelve month low of $35.05 and a twelve month high of $49.41. The stock’s fifty day moving average price is $44.04 and its two-hundred day moving average price is $44.97.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.